Statistics for The PPARγ Agonist Rosiglitazone Suppresses Syngeneic Mouse SCC (Squamous Cell Carcinoma) Tumor Growth through an Immune-Mediated Mechanism

Total visits

views
The PPARγ Agonist Rosiglitazone Suppresses Syngeneic Mouse SCC (Squamous Cell Carcinoma) Tumor Growth through an Immune-Mediated Mechanism 153

Total visits per month

views
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0

File Visits

views
molecules-24-02192.pdf 111
java.util.UUID:cf13d315-f8c4-4d32-ad2c-0832c39d8cd9 29
java.util.UUID:ef5fd268-8d95-4dbe-af58-8259d5248916 14
java.util.UUID:7351722b-9a3c-45fe-9eca-c555176324e8 12

Top country views

views
United States 109
Sweden 8
Germany 5
Ukraine 4
China 3
Canada 2
United Kingdom 2
Russia 2
Lebanon 1
Malaysia 1

Top city views

views
Wilmington 46
Fairfield 13
Stockholm 8
White Plains 7
Houston 6
Jacksonville 5
Cambridge 4
Kiev 4
Kiez 4
Ann Arbor 3
Beijing 2
Brooklyn 2
Toronto 2
Anderson 1
Beirut 1
Gunzenhausen 1
Moscow 1
Mount Laurel 1
New York 1
Saint Petersburg 1
San Francisco 1
Scottsdale 1
Seattle 1
Seremban 1
Shenzhen 1
Washington 1